Balance Labs Stock Performance
| BLNC Stock | USD 0.21 0.00 0.00% |
On a scale of 0 to 100, Balance Labs holds a performance score of 9. The firm shows a Beta (market volatility) of -1.02, which signifies a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Balance Labs are expected to decrease slowly. On the other hand, during market turmoil, Balance Labs is expected to outperform it slightly. Please check Balance Labs' treynor ratio, as well as the relationship between the kurtosis and day typical price , to make a quick decision on whether Balance Labs' price patterns will revert.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Balance Labs are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting basic indicators, Balance Labs exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 5632.00 | |
| Total Cashflows From Investing Activities | -203.7 K |
Balance |
Balance Labs Relative Risk vs. Return Landscape
If you would invest 18.00 in Balance Labs on October 7, 2024 and sell it today you would earn a total of 3.00 from holding Balance Labs or generate 16.67% return on investment over 90 days. Balance Labs is currently generating 0.2564% in daily expected returns and assumes 2.0672% risk (volatility on return distribution) over the 90 days horizon. In different words, 18% of pink sheets are less volatile than Balance, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Balance Labs Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Balance Labs' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Balance Labs, and traders can use it to determine the average amount a Balance Labs' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.124
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BLNC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.07 actual daily | 18 82% of assets are more volatile |
Expected Return
| 0.26 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Balance Labs is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Balance Labs by adding it to a well-diversified portfolio.
Balance Labs Fundamentals Growth
Balance Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Balance Labs, and Balance Labs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Balance Pink Sheet performance.
| Return On Asset | 0.0771 | |||
| Operating Margin | 0.50 % | |||
| Current Valuation | 7.28 M | |||
| Shares Outstanding | 21.67 M | |||
| Price To Earning | 13.82 X | |||
| Price To Book | 79.24 X | |||
| Price To Sales | 8.12 X | |||
| Revenue | 624.59 K | |||
| EBITDA | (552.39 K) | |||
| Cash And Equivalents | 227.77 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 468.81 K | |||
| Book Value Per Share | (0.18) X | |||
| Cash Flow From Operations | (56) | |||
| Earnings Per Share | (0.04) X | |||
| Total Asset | 1.01 M | |||
| Retained Earnings | (1.09 M) | |||
| Current Asset | 205 K | |||
| Current Liabilities | 552 K | |||
About Balance Labs Performance
By analyzing Balance Labs' fundamental ratios, stakeholders can gain valuable insights into Balance Labs' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Balance Labs has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Balance Labs has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Balance Labs, Inc. operates as a consulting firm that provides business development and consulting services to startup and development-stage businesses in the United States and internationally. The company was incorporated in 2014 and is based in Miami Beach, Florida. Balance Labs operates under Consulting Services classification in the United States and is traded on OTC Exchange. It employs 4 people.Things to note about Balance Labs performance evaluation
Checking the ongoing alerts about Balance Labs for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Balance Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Balance Labs has some characteristics of a very speculative penny stock | |
| Balance Labs currently holds 468.81 K in liabilities. Balance Labs has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Balance Labs until it has trouble settling it off, either with new capital or with free cash flow. So, Balance Labs' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Balance Labs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Balance to invest in growth at high rates of return. When we think about Balance Labs' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 624.59 K. Net Loss for the year was (796.7 K) with profit before overhead, payroll, taxes, and interest of 479.12 K. | |
| Balance Labs currently holds about 227.77 K in cash with (56) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 87.0% of the company shares are held by company insiders |
- Analyzing Balance Labs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Balance Labs' stock is overvalued or undervalued compared to its peers.
- Examining Balance Labs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Balance Labs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Balance Labs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Balance Labs' pink sheet. These opinions can provide insight into Balance Labs' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Balance Pink Sheet analysis
When running Balance Labs' price analysis, check to measure Balance Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Balance Labs is operating at the current time. Most of Balance Labs' value examination focuses on studying past and present price action to predict the probability of Balance Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Balance Labs' price. Additionally, you may evaluate how the addition of Balance Labs to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |